Wu J - Search Results

1

Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells.

Yang Y, Wang Y, Che X, Hou K, Wu J, Zheng C, Cheng Y, Liu Y, Hu X, Zhang J. Yang Y, et al. Among authors: wu j. Oncol Lett. 2021 Jul;22(1):556. doi: 10.3892/ol.2021.12817. Epub 2021 May 24. Oncol Lett. 2021. PMID: 34084223 Free PMC article.

2

Corrigendum: CircHIPK3 Promotes Metastasis of Gastric Cancer via miR-653-5p/miR-338-3p-NRP1 Axis Under a Long-Term Hypoxic Microenvironment.

Jin Y, Che X, Qu X, Li X, Lu W, Wu J, Wang Y, Hou K, Li C, Zhang X, Zhou J, Liu Y. Jin Y, et al. Among authors: wu j. Front Oncol. 2021 Nov 12;11:783320. doi: 10.3389/fonc.2021.783320. eCollection 2021. Front Oncol. 2021. PMID: 34869038 Free PMC article.

3

Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.

Chen Y, Wu J, Yan H, Cheng Y, Wang Y, Yang Y, Deng M, Che X, Hou K, Qu X, Zou D, Liu Y, Zhang Y, Hu X. Chen Y, et al. Among authors: wu j. Pharmacol Res. 2020 Sep;159:105007. doi: 10.1016/j.phrs.2020.105007. Epub 2020 Jun 17. Pharmacol Res. 2020. PMID: 32561477 Free article.

4

CircHIPK3 Promotes Metastasis of Gastric Cancer via miR-653-5p/miR-338-3p-NRP1 Axis Under a Long-Term Hypoxic Microenvironment.

Jin Y, Che X, Qu X, Li X, Lu W, Wu J, Wang Y, Hou K, Li C, Zhang X, Zhou J, Liu Y. Jin Y, et al. Among authors: wu j. Front Oncol. 2020 Aug 13;10:1612. doi: 10.3389/fonc.2020.01612. eCollection 2020. Front Oncol. 2020. PMID: 32903845 Free PMC article.

5

LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma.

Wu J, Zheng C, Wang Y, Yang Z, Li C, Fang W, Jin Y, Hou K, Cheng Y, Qi J, Qu X, Liu Y, Che X, Hu X. Wu J, et al. Biomark Res. 2021 Jan 30;9(1):9. doi: 10.1186/s40364-021-00262-3. Biomark Res. 2021. PMID: 33516270 Free PMC article.

6

Correction to: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma.

Wu J, Zheng C, Wang Y, Yang Z, Li C, Fang W, Jin Y, Hou K, Cheng Y, Qi J, Qu X, Liu Y, Che X, Hu X. Wu J, et al. Biomark Res. 2021 Apr 14;9(1):25. doi: 10.1186/s40364-021-00279-8. Biomark Res. 2021. PMID: 33853674 Free PMC article. No abstract available.

7

LRIG2 expression and prognosis in non-small cell lung cancer.

Wang G, Wu J, Song H. Wang G, et al. Among authors: wu j. Oncol Lett. 2014 Aug;8(2):667-672. doi: 10.3892/ol.2014.2157. Epub 2014 May 19. Oncol Lett. 2014. PMID: 25013483 Free PMC article.

8

Expression of WASF3 in patients with non-small cell lung cancer: Correlation with clinicopathological features and prognosis.

Wu J, Wang GC, Chen XJ, Xue ZR. Wu J, et al. Oncol Lett. 2014 Sep;8(3):1169-1174. doi: 10.3892/ol.2014.2276. Epub 2014 Jun 23. Oncol Lett. 2014. PMID: 25120680 Free PMC article.

9

Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer.

Wang XH, Zhang J, Wu J, He XH, Shen YR, Peng YG, An YZ. Wang XH, et al. Among authors: wu j. Front Oncol. 2022 Mar 30;12:840453. doi: 10.3389/fonc.2022.840453. eCollection 2022. Front Oncol. 2022. PMID: 35433492 Free PMC article.

10

Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule Nocardia rubra Cell-Wall Skeleton.

Wu J, He B, Miao M, Han X, Dai H, Dou H, Li Y, Zhang X, Wang G. Wu J, et al. Pathol Oncol Res. 2022 Aug 30;28:1610555. doi: 10.3389/pore.2022.1610555. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36110249 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,514 results

Search Page

Filters